Provided by Tiger Trade Technology Pte. Ltd.

FOSUN PHARMA

16.510
-0.780-4.51%
Volume:8.50M
Turnover:140.91M
Market Cap:43.90B
PE:11.13
High:17.200
Open:17.200
Low:16.360
Close:17.290
52wk High:28.232
52wk Low:14.505
Shares:2.66B
HK Float Shares:540.97M
Volume Ratio:1.49
T/O Rate:1.57%
Dividend:0.46
Dividend Rate:2.76%
EPS(LYR):1.484
ROE:6.95%
ROA:1.40%
PB:0.77
PE(LYR):11.13
PS:0.88

Loading ...

Regent Pacific Gets $4.5 Million Milestone Payment from Fosun Pharma Unit

MT Newswires Live
·
Sep 01

Fosun Pharma Repurchases 264,000 H Shares, Reducing Free Float by 0.05%

Bulletin Express
·
Sep 01

Fosun Pharma Spends HK$4.28 Million on Share Buyback on September 1

Stock News
·
Sep 01

Fosun Pharma Repurchases 70,500 H Shares for HKD 1.13 Million, Boosting Treasury Stock to 11.26 Million

Bulletin Express
·
Aug 31

Fosun Pharma Allocates 725,100 A-Share Options to Employees

Stock News
·
Aug 28

Fosun Pharma Grants 0.73 Million A-Share Options at RMB 27.93 Each Under 2025 Scheme

Bulletin Express
·
Aug 28

Shanghai Fosun Pharmaceutical's GR1803 Injection Gets Conditional Approval in China

MT Newswires Live
·
Aug 28

Fosun Pharma Secures Conditional NMPA Approval for GR1803 Injection

Stock News
·
Aug 27

Shanghai Fosun Pharma - Recently, Marketing Registration Application for Gr1803 Injection Has Been Approved with Conditions by Nmpa China

THOMSON REUTERS
·
Aug 27

Fosun Pharma Completes HK$3.587 Million Share Buyback on August 27

Stock News
·
Aug 27

Sinopharm Group Stock Rallies 1.1% in Hong Kong

Dow Jones
·
Aug 26

Fosun Pharma's H1 Report: Innovative Drug Revenue Surges 13.8% as Global Expansion Spans Three Continents

Deep News
·
Aug 26

Fosun Pharma Posts Flat Profit Growth in H1, Revenue Up 4.8%

MT Newswires Live
·
Aug 26

Press Release: Fosun Pharma Announces 2026 Interim Results

Dow Jones
·
Aug 25

Sinopharm Group Stock Falls 1.9% in Hong Kong

Dow Jones
·
Aug 24

Earning Preview: FOSUN PHARMA this quarter’s revenue is expected to increase by 8.56%, and institutional views are broadly bullish

Earnings Agent
·
Aug 18

Fosun Pharma Subsidiary Enters Collaboration Framework and License Agreement

Stock News
·
Aug 17

Shanghai Fosun's Unit in Collaboration with Sandoz AG on 10 Biologic Products

Reuters
·
Aug 17

Shanghai Fosun Pharmaceutical Says to Team up Sandoz on Commercialization, Development, Manufacturing of up to 10 Biologic Products

THOMSON REUTERS
·
Aug 17

Shanghai Fosun Pharmaceutical Says Unit Signs Framework Cooperation Agreement with Sandoz Ag

THOMSON REUTERS
·
Aug 17